More precisely, osteoblast-derived TGFβ1 stimulates, among others, the AKT/NFKB axis and, therefore, enhances the transmembrane adhesion receptor integrin β1 and β3-mediated migration of breast cancer cells [67]. Here, TGFB1 is linked to breast carcinoma.